For: | Sinn DH, Lee HI, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Virological response to adefovir monotherapy and the risk of adefovir resistance. World J Gastroenterol 2011; 17(30): 3526-3530 [PMID: 21941420 DOI: 10.3748/wjg.v17.i30.3526] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i30/3526.htm |
Number | Citing Articles |
1 |
Thuan Duc Lao, Hung Chi Lieu, Thuy Thanh Thi Ho, Thuy Ai Huyen Le. 7th International Conference on the Development of Biomedical Engineering in Vietnam (BME7). IFMBE Proceedings 2020; 69: 605 doi: 10.1007/978-981-13-5859-3_103
|
2 |
Dan-Hong Yang, Yuan-Jun Xie, Nian-Feng Zhao, Hong-Ying Pan, Ming-Wei Li, Hai-Jun Huang. Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients. World Journal of Gastroenterology 2015; 21(9): 2746-2753 doi: 10.3748/wjg.v21.i9.2746
|
3 |
Qian Zhang, Da-Chuan Cai, Peng Hu, Hong Ren. Low-level viremia in nucleoside analog-treated chronic hepatitis B patients. Chinese Medical Journal 2021; 134(23): 2810 doi: 10.1097/CM9.0000000000001793
|
4 |
Jun Li, Xiao-Qin Dong, Li-Hua Cao, Zhan-Qing Zhang, Wei-Feng Zhao, Qing-Hua Shang, Da-Zhi Zhang, An-Lin Ma, Qing Xie, Hong-Lian Gui, Guo Zhang, Ying-Xia Liu, Jia Shang, Shi-Bin Xie, Yi-Qi Liu, Chi Zhang, Gui-Qiang Wang, Hong Zhao. Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1151899
|
5 |
Fen Liu, Xiwei Wang, Fang Wei, Huaidong Hu, Dazhi Zhang, Peng Hu, Hong Ren. Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis. Virology Journal 2014; 11(1) doi: 10.1186/1743-422X-11-59
|